Sartorius records dynamic start to the new fiscal year
Global political and economic uncertainties substantially increased
“Sartorius had a good start to 2022. We continued to grow in both divisions and also achieved a further slight margin increase despite rising logistics and material costs as well as negative influences from currencies. The pandemic-related effects and the development of order intake are normalizing, as expected. Demand for our products is high in all segments, and our investments in the expansion of production capacities are making good progress. In addition, the acquisitions of Automated Lab Solutions and the chromatography business of Novasep strengthened the positioning of both divisions. In light of the positive performance in the first three months and the healthy demand situation, we are confirming our outlook for the current fiscal year. However, the global political and economic uncertainties have increased substantially with the outbreak of war in Ukraine, further increasing the strain on supply chains and the risks arising from significantly higher inflation rates,” said Executive Board Chairman and CEO Joachim Kreuzburg.
Business development of the Group
In the first quarter, Group sales revenue rose by 25.4 percent year-over-year in constant currencies (reported: + 29.5 percent) to around 1,025 million euros. The performance was driven by strong organic growth in both divisions, while acquisitions contributed almost 2 percentage points to the increase. All three business regions – EMEA, Americas, and Asia | Pacific – posted double-digit percentage growth in constant currencies.
Order intake was in line with expectations compared with the exceptionally strong prior-year quarter, reaching 1,112 million euros (- 5.8 percent in constant currencies; reported: - 2.3 percent). In the Bioprocess Solutions Division, in particular, the first quarters of 2021 were influenced by extraordinarily high demand related to the coronavirus pandemic and changed ordering patterns by some customers, who placed their orders further in advance than usual.
As a result from the growth in sales revenue, underlying EBITDA rose by 32.4 percent to 349 million euros in the first quarter. The corresponding margin improved to 34.1 percent, up from 33.3 percent a year earlier, despite being impacted by negative currency effects. Relevant net profit rose by 37.5 percent from the prior-year period to 167 million euros. Underlying earnings were 2.44 euros (prior-year quarter: 1.77 euros) per ordinary share and 2.45 euros (prior-year quarter: 1.78 euros) per preference share.
Key financial indicators
The Sartorius Group continues to have a very sound balance sheet and financial base. As of March 31, 2022, its equity ratio stood at 33.1 percent (December 31, 2021: 30.2 percent). Net debt to underlying EBITDA was 1.4 as of the reporting date, compared with 1.5 at year-end 2021. Cash flow from investing activities stood at –99 million euros as planned, compared to –90 million euros in the first quarter of 2021. The ratio of capital expenditures (CAPEX) to sales revenue reached 9.4 percent, compared with 10.2 percent in the prior-year period.
Increase in the number of employees
As of March 31, 2022, Sartorius employed a total of 15,051 people worldwide, representing a headcount increase of 1,219 from the end of December 2021.
Business development of the Bioprocess Solutions Division
The Bioprocess Solutions Division, which offers a wide array of innovative technologies for the manufacture of biopharmaceuticals and vaccines, recorded a year-over-year sales revenue increase of 29.2 percent in constant currencies (reported: + 33.4 percent) to 815 million euros in the first quarter. All business areas contributed to this development with clear double-digit growth rates. The non-organic contribution from acquisitions was around 2 percentage points.
As expected, order intake fell by 9.8 percent in constant currencies (reported: - 6.6 percent) to 890 million euros on the back of the exceptionally high figure for the prior-year period, which was influenced by changed ordering patterns by some customers, who placed orders further in advance than usual, and strong demand from manufacturers of coronavirus vaccines.
Underlying EBITDA of the Bioprocess Solutions Division rose by 35.1 percent to 293 million euros, with the corresponding margin increasing to 36.0 percent (prior-year quarter: 35.6 percent) despite negative currency effects.
Business development of the Lab Products & Services Division
The Lab Products & Services Division, which specializes in equipment and technologies for life science research and pharmaceutical laboratories, increased its sales revenue by 12.4 percent in constant currencies (reported: + 16.5 percent) to 210 million euros in the first quarter. Close to 1 percentage point came from non-organic growth. Development was once again especially dynamic in the bioanalytics product segment. Order intake grew slightly faster than sales revenue, rising by 15.2 percent in constant currencies (reported: + 19.9 percent) to 223 million euros.
The division's underlying EBITDA rose by 20.1 percent to 56 million euros, translating into a margin increase to 26.5 percent (prior-year quarter: 25.7 percent), despite negative currency effects.
Outlook for fiscal 2022 confirmed
The management confirms the outlook for the current fiscal year. Consolidated sales revenue is expected to increase by about 15 percent to 19 percent, with non-organic growth from acquisitions projected to contribute about 2 percentage points. The company’s underlying EBITDA margin is expected to reach about 34 percent this year.
For the Bioprocess Solutions Division, the company forecasts sales revenue growth of about 17 percent to 21 percent. This includes a non-organic growth contribution from acquisitions of about 2 percentage points. The division's underlying EBITDA margin is projected to reach about 36 percent. Lab Products & Services should achieve revenue growth of about 6 percent to 10 percent in 2022, with about 1 percentage point of this coming from the non-organic growth contribution from acquisitions. The division’s underlying EBITDA margin is expected to be about 26 percent.
The CAPEX ratio is anticipated to be about 14 percent and net debt to underlying EBITDA to be about 1.1 at year-end. Possible further acquisitions are not included in this projection.
Other news from the department business & finance
Eppendorf and Neste forge strategic partnership to develop new line of renewable lab plastics
A sustainable choice for labs
Merck Expands Newest Biologics Testing Center in Shanghai
Further develops its biosafety testing laboratories to meet local demand
Spacetek Technology announces the successful closing of its Seed Financing Round
Time-of-flight mass spectrometers (TOF-MS) inspired by space technology
Start-up Better Basics Laborbedarf Wins First Place at the "Wiley Analytical Science Award 2024"
SmartRack® wins in the Separation, Laboratory Automation & Equipment Category
Verici DX reaches a global licensing and commercialisation agreement with Thermo Fisher Scientific
Agreement grants rights to further develop an assay for pre-transplant prognostic testing
analytica 2024: Food analysis for sustainable nutrition
From PFAS to microplastics: focus on new harmful substances
HunterLab Spreads Its Vibrant Colors to Europe: Introducing 'HunterLab Europe'
Steering HunterLab Europe is none other than the Christian Jansen, who literally grew up in the color spectrophotometry world
HeartBeat.bio raises € 4.5 million in Pre-Series A financing
New funds to drive development of organoid screening platform for cardiac drug discovery
Huber Kältemaschinenbau receives highest award at the "Großer Preis des Mittelstandes" (Grand Prix of Medium-Sized Businesses)
Fraunhofer IPA transfers rights to use laboratory robot KEVIN United Robotics Group
KEVIN can be flexibly and intuitively integrated into laboratory infrastructures and automates processes
analytica 2024 presents the laboratory world of tomorrow
Focus topics are digitization and sustainability
SRI spins off AI-powered drug discovery platform Synfini, Inc.
Synfini to commercialize and scale automated compound testing for rapid drug production
Cytomos welcomes new Director
£4 million investment sets path for commercialisation of groundbreaking cell analysis technology
Beckman Coulter and Fujirebio enter into partnership
The goal is a patient-friendly, blood-based Alzheimer's disease test
Metallographic image analysis in second
TGFS invests in start-up for AI-based software for microstructure analysis
Start-up recycles plastic lab waste into new test tubes and petri dishes
University of Bath is home to UK’s first pilot plant for recycling plastic lab waste
Most read news
Autonomous measuring instruments systematically detect new materials
A new algorithm measures materials libraries up to four times faster than before: It’s based on machine learning
Aston University technology to combat the not-so sweet practice of honey fraud
Light technology to be used to detect if honey is blended with cheap additions
Researchers discover new ultra strong material for microchip sensors
A material that doesn't just rival the strength of diamonds and graphene, but boasts a yield strength 10 times greater than Kevlar
Scientists use quantum biology, AI to sharpen genome editing tool
"This study represents an exciting advancement toward, understanding how we can avoid making costly ‘typos’ in an organism’s genetic code"
Fatty acid factory filmed at work
High-resolution images provide new insights into cellular fatty acid production: Potential for medicine and biotechnology
Tracking down Environmental Toxins
Detection of per- and polyfluoroalkyl substances (PFAS) by interrupted energy transfer
‘Hot’ new form of microscopy examines materials using evanescent waves
“This microscope technology is completely new, so we’re still learning specifically how and where it can be applied”
Viral Impostors: Breakthrough for Virus Research
The penetration of viruses into cells can now be tracked with unprecedented accuracy thanks to innovative design for pseudoviruses
Award for innovation in the detection of PFAS compounds
Thuringian startup and Fraunhofer Institute receive Lothar Späth Award
More news from our other portals
Microbes could help reduce the need for chemical fertilizers
A coating protects nitrogen-fixing bacteria: Start-up to commercialise coated bacteria for large-scale use in regenerative agriculture
Bowel cancer: aspirin activates protective genes
Researchers have identified a signaling pathway by which aspirin can inhibit colorectal cancer.
Dunning-Kruger effect with muesli bars
Those who know the least consider themselves highly competent
Plastic-eating bacteria turn waste into useful starting materials for other products
Microbial Upcycling of Waste PET
New drug delivery system could reduce daily diabetes shots to just three a year
Dietary management drugs have transformed Type 2 diabetes care, but daily injection routines are challenging for some patients
Inauguration of the world’s first pilot plant for the cost-efficient production of green methanol
Start-up C1 Green Chemicals AG and research partners develop fundamentally new production process
Naked Clams: The New Superfood Sensation Emerging from the Depths
Researchers found Naked Clams contain almost twice the amount of Vitamin B12 as blue mussels and have developed an efficient way to farm them
New designs for solid-state electrolytes may soon revolutionize the battery industry
Scientists achieve monumental improvements in lithium-metal-chloride solid-state electrolytes
This is a battery
Two colored liquids bubbling through tubes: Is this what the battery of the future looks like?
Pushers, overcrowded trains and phone zombies
Sprite presents the world's first vending machine that responds to the things that bother Generation Z the most
Converting PFAS “forever chemicals” into valuable compounds
Scientists develop a new method to incorporate harmful perfluoroalkenes into N-heterocyclic carbene ligands
Tönnies Group launches first nationwide "Meat Climate Platform"
100 guests at the Future Forum for Agriculture
Not so silver lining: Microplastics found in clouds could affect the weather
Low-altitude and denser clouds contained greater amounts of microplastics
From the trough to the plate - digitally calculated
Computer program "ConTrans" estimates how much of an undesirable substance is transferred from animal feed to food
Graphene's proton permeability: A switch for future energy technologies
This discovery could lead to the development of more efficient hydrogen fuel cells and solar water-splitting devices
The weight of pollution: exposure linked to obesity
Chronic exposure to environmental pollutants found to increase risk of cardiovascular disease
Lithium-ion batteries are no longer the gold standard in battery tech
On the way to safer and more powerful energy sources
Textbook knowledge turned on its head: 3-in-1 microorganism discovered
Newly multifunctional bacterial species
Are healthy foods automatically sustainable, too?
Perceptions about sustainability and healthy food choices are closely linked
Dow and Evonik announce startup of hydrogen peroxide to propylene glycol (HPPG) pilot plant
Innovative technology offer flexibility, lower costs, and a smaller environmental footprint
The Largest Biotech City in Europe Will Soon Be Built
The entire BIO CITY complex will span an area equivalent to 10 football fields, total investment expected to reach around 7 billion euros